je.st
news
Esperion Announces Positive Topline Results from a Phase 2 Clinical...
2013-01-08 02:44:31| Biotech - Topix.net
Esperion Therapeutics, the leading developer of small molecule therapies for the treatment of cardiometabolic disorders, today announced positive results of a recently completed Phase 2 clinical trial of ETC-1002 in patients with type 2 diabetes with LDL-C lowering of up to 43% compared to placebo.
Tags: results
positive
phase
clinical
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||